Therapeutic Regeneration of Lymphatic and Immune Cell Functions upon Lympho-organoid Transplantation. by Lenti, Elisa et al.
s
o
u
r
c
e
:
 
ht
tp
s:
//
do
i.
or
g/
10
.7
89
2/
bo
ri
s.
13
46
90
 
| 
do
wn
lo
ad
ed
: 
4.
12
.2
01
9Stem Cell Reports
ReportTherapeutic Regeneration of Lymphatic and Immune Cell Functions upon
Lympho-organoid Transplantation
Elisa Lenti,1 Silvia Bianchessi,1 Steven T. Proulx,2 Maria Teresa Palano,1 Luca Genovese,1 Laura Raccosta,3
Antonello Spinelli,4 Denise Drago,5 Annapaola Andolfo,5 Massimo Alfano,6 Tatiana V. Petrova,7
Sylvain Mukenge,8 Vincenzo Russo,3 and Andrea Brendolan1,*
1Unit of Lymphoid Organ Development, Division of Experimental Oncology, DIBIT-1 3A2, IRCCS San Raffaele Scientific Institute, Via Olgettina 60, 20132
Milan, Italy
2Institute of Pharmaceutical Sciences, Swiss Federal Institute of Technology, ETH Zurich, 8093 Zurich, Switzerland
3Unit of Immuno-Biotherapy ofMelanoma and Solid Tumors, Division of Experimental Oncology, IRCCS San Raffaele Scientific Institute, 20132Milan, Italy
4Experimental Imaging Centre, IRCCS San Raffaele Scientific Institute, 20132 Milan, Italy
5ProMiFa, Protein Microsequencing Facility, IRCCS San Raffaele Scientific Institute, 20132 Milan, Italy
6Division of Experimental Oncology/Unit of Urology, URI, IRCCS Ospedale San Raffaele, Milan, Italy
7Department of Oncology, University of Lausanne, and Ludwig Institute for Cancer Research, 1066 Lausanne, Switzerland
8Department of Hepatobiliary Surgery, IRCCS San Raffaele Hospital, 20132 Milan, Italy
*Correspondence: brendolan.andrea@hsr.it
https://doi.org/10.1016/j.stemcr.2019.04.021SUMMARYLymph nodes (LNs) are secondary lymphoid tissues that play a critical role in filtering the lymph and promoting adaptive immune
responses. Surgical resection of LNs, radiation therapy, or infections may damage lymphatic vasculature and compromise immune
functions. Here, we describe the generation of functional synthetic lympho-organoids (LOs) using LN stromal progenitors and decellu-
larized extracellular matrix-based scaffolds, two basic constituents of secondary lymphoid tissues. We show that upon transplantation at
the site of resected LNs, LOs become integrated into the endogenous lymphatic vasculature and efficiently restore lymphatic drainage
and perfusion. Upon immunization, LOs support the activation of antigen-specific immune responses, thus acquiring properties of
native lymphoid tissues. These findings provide a proof-of-concept strategy for the development of functional lympho-organoids
suitable for restoring lymphatic and immune cell functions.INTRODUCTION
Lymph node (LN) development is a multistep process
involving crosstalk of multiple cell types and culminating
in integration of LNs into the lymphatic system (Brendolan
and Caamano, 2012; Onder and Ludewig, 2018). Non-
hematopoietic stromal progenitors of lymphoid organs
play critical roles in tissue development, organization,
and function through the secretion of cytokines, chemo-
kines, and the extracellularmatrix (ECM), a tri-dimensional
scaffold that provides structural support and anchorage for
cells (Benezech et al., 2012; Lokmic et al., 2008;Onder et al.,
2017; Petrova and Koh, 2018). Afferent-collecting lym-
phatics transport lymph and antigens to the LN where im-
mune responses are generated (Petrova and Koh, 2018).
However, surgical resection of LNs, radiation therapy, or in-
fections may damage the lymphatic vasculature and
contribute to secondary lymphedema, a chronic disease
characterized by excessive tissue swelling, fibrosis, and
decreased immune responses (Alitalo, 2011). Currently
available lymphedema treatments are limited to manual
lymph drainage and compression garments, and definitive
therapeutic options are still lacking (Andersen et al., 2000).
Vascularized autologous lymphnode transfer (ALNT), a sur-
gical procedure in which a LN flap is harvested and trans-
planted at the site of resected LNs to improve lymphatic1260 Stem Cell Reports j Vol. 12 j 1260–1268 j June 11, 2019 j ª 2019 The A
This is an open access article under the CC BY-NC-ND license (http://creativdrainage, is emerging as a therapeutic option for the treat-
ment of cancer-associated lymphedema (Becker et al.,
2006; Kanapathy et al., 2014; Scaglioni et al., 2018).
Although feasible, such an approach requires surgical inter-
vention and can be associated with donor-site complica-
tions, which may limit its application (Gould et al., 2018).
To circumvent these problems, tissue engineering may
provide strategies to develop artificial lymphoid tissues
for applications in regenerative medicine (Nosenko et al.,
2016; Purwada et al., 2015; Cupedo et al., 2012). It has
been demonstrated that transplantation under the kidney
capsule of an engineered stromal cell line expressing lym-
photoxin a in a biocompatible scaffold or the delivery of
stromal-derived chemokines in hydrogel is sufficient to
promote the organization of lymphoid-like structures
with immunological function (Castagnaro et al., 2013; Su-
ematsu and Watanabe, 2004; Kobayashi and Watanabe,
2016). Whether these approaches contribute to regenerate
immune and lymphatic functions in preclinical models of
LN resection remains unknown.
Here, we generated lympho-organoids (LOs) using LN
stromal progenitors in an ECM-based scaffold and show
thatLOtransplantationat the siteof resectedLNcontributes
to restoration of lymphatic and immune functions. Upon
transplantation, LOs are integrated into the endogenous
lymphatic vasculature and efficiently restore lymphaticuthor(s).
ecommons.org/licenses/by-nc-nd/4.0/).
A B
C
D
Figure 1. Generation of Vascularized
Lympho-Organoids Using Lymphoid Stro-
mal Progenitors and ECM-Based Scaffold
(A) Macroscopic view of ECM before and
after decellularization, DAPI (nuclei), and
Sirius red (collagens) staining. Represen-
tative scanning electron microscopy (SEM)
image to visualize the dense network of
collagen fibers and the presence of glycos-
aminoglycan aggregates (yellow arrow).
Scale bars: 50 mm (DAPI and Sirius red) and
1 mm (SEM).
(B) Nano-liquid chromatography mass
spectrometry analysis. Graph indicate
commonalities in protein identities.
(C) Scheme of YFP+ stromal progenitors
cultured on top of the dECM in a tri-
dimensional (3D) configuration for 48 h,
and macroscopic view of the resulting pre-
assembled LOs (pre-LOs). Representative
confocal images of tissue sections stained
for YFP (Stroma, in green) and for COLL-IV
(ECM, in red). Nuclei visualized by DAPI.
Scale bars: 200 mm and 100 mm.
(D) Scheme of transplantation of pre-LOs to
the mouse renal subcapsular space of Prox1-
mOrange2 reporter mice. Graph represents
the number of mice containing clusters of
lymphoid cells (15 mice analyzed in total).
Representative confocal images of LOs
3 weeks after transplant. Tissue sections
were stained for CD3 (T cell; red, upper
panel), B220 (B cells; gray, upper panel),
PECAM-1 (blood endothelial cells; red,
lower panel), PROX-1 (lymphatic endothe-
lial cells; green, lower panel), and DAPI
(nuclei; blue) to visualize nuclei and iden-
tify B/T cell clusters. Scale bars: 100 mm and
50 mm. Images are representative of three
independent experiments.drainage and perfusion. Notably, upon immunization, LOs
support the activation of antigen-specific immune re-
sponses and acquire properties of native lymphoid tissues.
These findings provide a robust preclinical approach for
the development of synthetic LOs capable of regenerating
lymphatic and immune functions.RESULTS AND DISCUSSION
Generation of Vascularized Lympho-Organoids Using
a Decellularized Stromal ECM-Based Scaffold and
Lymphoid Stromal Progenitors
We hypothesized that the delivery of primary LNs stromal
progenitors embedded in a physiological ECM-based scaf-fold may be sufficient to initiate the organization of func-
tional LOs. To this end, we first generated an ECM-based
scaffold by culturing a spleen stromal cell line in the pres-
ence of ascorbate, that promotes collagen deposition (Fig-
ure S1A) (Franco-Barraza et al., 2016; Genovese et al.,
2014). At day 10 of treatment, stromal cells formed a
densely packed monolayer that was decellularized using a
previously published protocol adapted to our culture con-
ditions (Figures S1A and 1A) (Franco-Barraza et al., 2016;
Genovese et al., 2014). The decellularized ECM (dECM) ap-
peared as a thin and elastic layer characterized by a network
of collagen fibers that was confirmed by ultrastructural
analysis using scanning electron microscopy (Figure 1A).
Lectin-peanut agglutinin (PNA) staining also revealed the
presence of ECM-associated glycoproteins (Figure S1B).Stem Cell Reports j Vol. 12 j 1260–1268 j June 11, 2019 1261
To gain insights into the proteomic landscape, we per-
formed mass spectrometry (MS) analysis and related the
composition of the dECM to that of a decellularized
splenic tissue (dSPL) (Figure 1B). The list of proteins ob-
tained (ProteomeXchange: PXD013250) was compared
with that of proteins annotated in the Mouse Matrisome
Database atlas, a database of all known ECM proteins
(Naba et al., 2016). The results showed a large degree of
similarities between the two tissues with 58 (60%) com-
mon proteins out of 113 not significantly different in
dSPL versus dECM (p < 0.01) (Figure 1B and Table S1).
Notably, the dECM contained components of the inter-
stitial matrix (Collagens I and III, FN, TN-C), basement
membrane (COLL-IV, LAM-a5, NID2), and secreted
proteins and regulators of ECM biology, indicating
that its composition is more physiological compared
with commercially available scaffolds, which are mostly
made of single ECM components.
To assess the ability of dECM to promote stromal cell
adhesion, we isolated primary LN stromal progenitors
from neonatal mice and expanded them for 10 days
in vitro. The phenotypic analysis revealed the presence
of a homogeneous population of non-endothelial
GP38+ stromal progenitors (Figure S2A). These stromal
progenitors, when seeded on top of the dECM, firmly
adhered to the matrix and showed an elongated arrange-
ment (Figure S1C). We then pre-assembled a lympho-
organoid (pre-LO) by culturing stromal progenitors
isolated from green fluorescence reporter mice onto the
dECM in a three-dimensional (3D) configuration for
48 h (Figure 1C). The resulting structures appeared com-
pacted and resembled native LNs in shape and dimen-
sions (Figure 1C). Immunofluorescence staining revealed
a network of stromal precursors adherent to the dECM
and evenly distributed throughout the organoid (Fig-
ure 1C). To assess whether pre-LOs support vasculariza-
tion and infiltration of lymphoid cells, we transplanted
them under the mouse renal subcapsular space (Fig-
ure 1D). Three weeks later, the grafts appeared larger
compared with that originally transplanted, and immu-
nofluorescence staining revealed that a large fraction
(50%) of LOs contained clusters of CD3+ T and B220+ B
cells together with blood (PECAM-1+) and lymphatic
(PROX-1+) endothelial cells (Figure 1D). Altogether, these
findings indicate that the transplantation of pre-LOs
generated with basic constituents of lymphoid organs is
sufficient to initiate organization of LOs with features
of native tissues.
Transplantation of Lympho-Organoids at the Site of
Resected Lymph Nodes Restores Lymphatic Drainage
To assess whether LOs are functional in restoring
lymphatic drainage, we exploited an approach in which1262 Stem Cell Reports j Vol. 12 j 1260–1268 j June 11, 2019the surgical dissection of axillary/brachial LNs models
the resection of LNs during cancer surgery, a procedure
that contributes to the development of lymphedema
(Blum et al., 2013). Although in mice this procedure does
not cause macroscopic lymphedema, because of their
small size and minimal lymphatic pressure gradients, it
allows us to evaluate whether transplanted LOs contribute
to lymphatic drainage. To this end, we performed resection
of axillary/brachial LNs together with a small portion of
the surrounding fat pad and lymphatics, which was fol-
lowed by LO transplantation (Figure 2A). Two months
later, lymphatic drainage was evaluated by measuring
near-infrared (NIR) fluorescence imaging in the region of
the axilla receiving the LO transfer (Proulx et al., 2013,
2017). Two minutes after injecting the P20D800 tracer
in the dorsal skin of the paw, we quantified by NIR
imaging the intensity of the region of interest (ROI) signal
over the axilla region. This analysis revealed that the signal
from the ROI of mice receiving pre-LOs (dECM + stromal
progenitors) after LN resection was comparable with that
of sham-operated control mice; whereas axillary LN-re-
sected mice with or without the dECM (alone) showed
low or no signal (Figure 2B). Notably, microcomputed to-
mography (mCT imaging) confirmed the presence of a
well-defined 3D structure in the axillary region only in
pre-LO transplanted and sham-operated control mice
(Figure 2B).
Lympho-Organoids Are Integrated into Pre-existing
Lymphatics and Support Lymphatic Perfusion
We then assessed whether transplanted LOs are perfused
and connected to endogenous LNs, a requisite for
proper lymphatic function. To test this, we measured
lymphatic perfusion after popliteal LN resection followed
by LO transplantation. To visualize endogenous lym-
phatics, we used reporter mice, which express an mOrange
fluorescence signal under the Prox-1 promoter (Figure 3A).
One month later, imaging of mice injected intradermally
with fluorescein isothiocyanate (FITC)-dextran revealed a
dense network of FITC+PROX1+ endogenous lymphatic
vessels surrounding and connecting to LOs (Figure 3B).
Longitudinal FITC and NIR imaging of the lymphatic
vasculature in transplanted limbs showed perfusion of
both the popliteal efferent vessel (EV) and the downstream
sacral LN (saLN) (Figures 3B and S3), suggesting that LOs
were integrated into the existing lymphatics and acquired
the capacity to support lymphatic perfusion. Notably,
quantification analysis revealed saLN perfusion in a signif-
icantly higher fraction (67%) of mice receiving LO transfer
compared with those that did not receive LOs (11%),
whereas no differences were observed in terms of dermal
backflow or afferent vessel perfusion between the two
groups (Figure 3D, Videos S1 and S2).
AB
Figure 2. Transplantation of Lympho-
Organoids at the Site of LN Resection
Promotes Lymphatic Drainage
(A) Scheme of transplantation of pre-LOs in
place of axillary/brachial dissected LNs.
(B) Representative images of the intensity
signal at the region of interest (ROI) through
live imaging (IVIS) and mCT-Scan showing the
localization of LOs. Mouse groups: control,
sham-operated; ALND, axillary LN dissected;
ALND + dECM (alone), axillary LN dissected
and transplanted with dECM alone; ALND +
pre-LO, axillary LN dissected and transplanted
with dECM and primary stromal progenitors.
Quantification analysis of the ROI value
(normalized versus background and signal at
site of injection) for each mouse analyzed.
Data presented as means ± SD from three in-
dependent experiments; n, total number of
mice analyzed for each experimental group.
Statistically significant comparisons: **p <
0.01 and ***p < 0.001.Lympho-Organoids Contain T and B Cell Clusters and
Support Antigen-Specific Immunity
Based on these findings, we tested whether LOs trans-
planted at the site of LN dissection become functional as
a reservoir of immune cells, a feature characteristic of
lymphoid tissues. Immunofluorescence staining per-
formed on LOs transplanted at the site of popliteal LN
showed the presence of PECAM-1+ blood and LYVE-1+
lymphatic endothelial cells (Figure 4A). Notably, around
70% of the harvested LOs (20 of 29) appeared highly infil-
trated with lymphoid cells. Among these, 60% of LOs con-
tained clearly segregated clusters of TandB cells (Figure 4B),
often associated with networks of CD35+ follicular den-
dritic cells (Figure 4B), whereas the remaining 40% con-
tained many infiltrated T cells with only a few B cells
(data not shown).
A requisite of LN functionality is the ability to mount
antigen-specific immune responses (Lim et al., 2016).
To test whether LOs have acquired this capability, we
performed LO transplantation at the popliteal site fol-
lowed by injection of CD8+ OT-I cells (5 3 106/mouse)
(Russo et al., 2007). Twenty-four hours later, mice wereimmunized intradermally in the footpad of the trans-
planted limb with ovalbumin (OVA)-peptide SIINFEKL
in adjuvant (OT-I + OVA) or received saline as a control
(OT-I) (Figure 4C). LOs and inguinal LNs (iLNs) were
collected 5 days post immunization, and the frequency
of OT-I CD8+ T cells was measured by fluorescence-acti-
vated cell sorter (FACS) staining of the Va2 and Vb5.1
chains of the transgenic (OT-I) T cell receptor. Notably,
LOs of immunized mice contained a substantial higher
percentage OT-I CD8+ T cells compared with control
mice, while the frequency of OT-I cells in iLNs was
similar between the two groups (Figure 4C). These find-
ings indicate that transplanted LOs acquire immunolog-
ical function.
To our knowledge, this is the first study to demonstrate
the feasibility of ex vivo pre-assembled synthetic LOs for
the therapeutic restoration of lymphatic and immune
cell functions in preclinical models. We have provided
a clinically relevant proof-of-concept approach to show
that two basic constituents of developing LN, lymphoid
stromal progenitors and the ECM, are sufficient to pro-
mote in vivo self-organization of functional LOs for tissueStem Cell Reports j Vol. 12 j 1260–1268 j June 11, 2019 1263
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Figure 3. Lympho-Organoids Are Con-
nected to Lymphatics and Promote
Lymphatic Perfusion
(A) Scheme of pre-LO transplantation at the
site of popliteal dissected LNs.
(B) Representative fluorescence images of LO
surrounded and infiltrated by FITC+PROX-1+
lymphatics (orange). Insets ii and iii are
magnifications from panel i. AV, afferent
vessel; EV, efferent vessel, LO, lympho-orga-
noid. Scale bars: 500 mm (panel i) and 200 mm
(ii and iii). Images are representative of two
independent experiments.
(C) Representative FITC and NIR fluorescence
images of lymphatic vasculature showing
connections between LOs and saLN through
EV. EV, efferent vessel; LO, lympho-organoid;
saLN, sacral LN. Images are representative of
two independent experiments. Scale bars:
1,000 mm.
(D) Quantification analysis of lymphatic
perfusion. Data presented as pooled number of
mice used from two independent experiments.
***p < 0.001.regeneration. Stromal cells may facilitate adhesion and
retention of lymphoid cells into the dECM and promote
integration of LO into lymphatics via secretion of
lymphangiogenic factors contributing to LO function.
Our findings indicate that after transplantation, LOs
remains for at least 2 months, although it remains
unclear if they endure over a longer period. Nevertheless,
our findings indicate that LOs may represent a therapeu-
tic approach to restore lymphatic and immune cell func-
tions in secondary lymphedema and other diseases in
which LNs have been removed or are dysfunctional.EXPERIMENTAL PROCEDURES
Mice
Prox1-mOrange2 mice have been described previously (Hagerling
et al., 2011). C57BL/6N mice were purchased from Charles River,
Italy. Animals were maintained in a specific pathogen-free animal
facility and treated in accordance with European Union and
Institutional Animal Care and Use Committee guidelines.
Cell Cultures and ECM Production
The immortalized stromal cell (iSC) line used for dECM prepara-
tion has been previously described (Farinello et al., 2018). Cells1264 Stem Cell Reports j Vol. 12 j 1260–1268 j June 11, 2019were cultured in Dulbecco’s modified Eagle’s medium (DMEM;
Gibco) supplemented with 10% fetal bovine serum (FBS; Euro-
clone), 1% L-glutamine (Gibco-Invitrogen), and 1% penicillin
(Gibco-Invitrogen) and incubated at 37C with 5% CO2. Cells
were split every 2 days using Trypsin (Gibco-Invitrogen), and
washing steps were performed with PBS 13. Primary stromal pro-
genitors (pSP) were obtained from neonatal mesenteric lymph
nodes (mLNs). mLNs were digested with 0.45 mg/mL Liberase
TM (05401119001, Roche) in a 1:1 ratio with FBS for 20 min at
37C under gentle shaking and pipetting every 10 min. mLN pri-
mary cell suspensions were seeded into 10 cm dishes and cultured
for 4 days. Primary cells were trypsinized, expanded, and cultured
for a maximum of 7–10 days, then used for LO generation. Each
primary cell preparation was tested using FACS to assess the
phenotype (detailed FACS analysis in Figure S2). For generation
of dECM, 8 3 105 cells were seeded on 0.2% gelatin-coated
60 mm Petri dishes and cultured to reach 80% confluence the
day after. Then, the medium was changed and supplemented
with 50 mg/mL of ascorbic acid (A4544, Sigma). The medium
was changed every second day (day 2, 4, 6, 8), and at day 10,
the cell layer was decellularized using a protocol previously pub-
lished and adapted to our culture conditions (Genovese et al.,
2014). All the decellularization steps were performed on a
rotating shaker, and the resulting dECM was washed with PBS
13 and stored under PBS 13 supplemented with 1% penicillin/
streptomycin at 4C for up to 1 month.
AB
C
Figure 4. Lympho-Organoids Support the Generation of Antigen-Specific Immunity
(A) Representative confocal images of transplanted LOs stained for DAPI (nuclei; blue), PECAM-1 (blood endothelial cells; red), and LYVE-1
(lymphatic endothelial cells; green). Scale bars: 50 mm. Images are representative of LOs from three independent experiments.
(B) Representative confocal images of LOs stained for DAPI (nuclei, blue), CD3 (T cells; red, upper panel), CD35 (follicular dendritic cells;
red, lower panel), B220 (B cells; green), and Collagen-IV (ECM; white). Graph represents the number of mice containing clusters of
lymphoid cells. Images are representative of LOs from three independent experiments.
(legend continued on next page)
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ECM Purification and Protein Identification Using
Nano-Liquid Chromatography MS/MS Analysis
Spleens were collected from three different C57BL6/N mice, and
spleen-derived ECM (dSPL) was prepared as described previously
(Genovese et al., 2014). The dECM sample was a pool of ten
dECMs from three different decellularizations. ECM proteins
were extracted, quantified, and processed by nano-liquid chro-
matography MS/MS analysis. For quantification of proteins,
the raw data were loaded into MaxQuant software version
1.5.2.8; label-free protein quantification was determined on
the intensities of precursors, both as protein intensities and
normalized protein intensities (LFQ intensities). Peptides and
proteins were accepted with a false discovery rate less than 1%
and a minimum of two peptides per protein with one unique.
The proteins identified by proteomic analysis were compared
with the Total Mouse Matrisome database (http://web.mit.edu/
hyneslab/matrisome/) updated in August 2014, when the data-
base comprised 1,110 genes coding for murine proteins in the
ECM. Hierarchical clustering of the 113 proteins that were
ascribed to the Mouse Matrisome was obtained using MeV
software (v. 4.9.0) with p < 0.01 considered for statistical
significance.
Immunohistochemistry, Immunofluorescence, and
Confocal Analyses
Decellularized ECM samples were washed with PBS 13, and
whole-mount staining was performed. For DAPI staining, DAPI
(Fluka-Sigma) was diluted in PBS 13 at 2 mg/mL and incubated
for 5 min at room temperature. dECM was washed three times
with PBS 13 and mounted with Mowiol (Calbiochem). For aLec-
tin-PNA staining, dECM was washed with PBS 13 with 0.05%
Tween (Sigma) (PBS-T) three times for 5 min and then incubated
with aLectin-PNA (Alexa Fluor 594-conjugated peanut agglu-
tinin lectin, L32459; Thermo Fisher) for 1 h at room tempera-
ture. dECM was then washed three times with PBS-T and
mounted with Mowiol. For Sirius red collagen staining, dECMs
were fixed with Bouin’s solution (71% saturated picric acid solu-
tion, 8.5% formalin, and 4.8% glacial acetic acid) and then
washed with tap water for 5 min. The sample was stained in
Sirius red solution (0.1% Sirius red F3Ba dye in saturated picric
acid solution) for 1 h at room temperature. The staining solu-
tion was discarded, samples were washed with 2% of acetic
acid and then incubated with EtOH:picric acid (1:1) for 5 min.
Finally, dECMs were dehydrated in EtOH, kept in a humid
chamber until image acquisition and mounted with Mowiol.
Microscopy images were obtained using a Nikon Eclipse TE200
fluorescence microscope, and final image processing was per-
formed with ImageJ or Adobe Photoshop and Illustrator. For
electron scanning microscopy, dECM was placed on a coverslip,
dewaxed, dehydrated with absolute ethyl alcohol, and dried
overnight in hexamethyldisilazane. Then, the sample was(C) Scheme of LO transplantation and immunization. FACS plot
inguinal LN. Gating strategy for flow cytometry. FACS plot analysis o
analysis of OT-I+ CD8 T cells in LO and iLN. Data are presented as mean
***p < 0.001.
1266 Stem Cell Reports j Vol. 12 j 1260–1268 j June 11, 2019coated with gold-palladium after evaporation of hexamethyldi-
silazane and examined in a Leica S420 scanning electron
microscope.Generation of Pre-assembled Lympho-Organoids
In Vitro
LOs were prepared by combining pSC and dECM. pSC cells (5 3
105) obtained from neonatal mLNs were resuspended in 500 mL
of complete DMEM, seeded on top of dECM, and incubated at
37C and 5% CO2. After 2–3 h of incubation, cells were firmly
adherent to dECM and could be packaged to obtain pre-LOs in
3D configuration and placed in ultra-low attachment 24-well
plates (#3473, Corning). These 3D pre-assembled structures were
incubated at 37C and 5% CO2 for 48 h for in vitro studies (immu-
nofluorescence) and only overnight for in vivo experiments
(transplantation).Statistical Analyses
Data were analyzed using GraphPad Prism 5 (GraphPad Software).
Statistical analysis was performed using a two-tailed unpaired Stu-
dent’s t test or c2 test, as indicated in the figure legends to evaluate
statistical differences among the samples. An asterisk denotes sta-
tistical significance as follows: *p < 0.05, **p < 0.01, ***p < 0.001.
All data are presented are as means ± SD. Group sizes were esti-
mated based on pilot studies to determine the success rate and
reproducibility of LO transplantation.Data Availability
The authors declare that all data supporting the findings of this
study are available within the manuscript or its supplementary
files or are available from the corresponding author upon reason-
able request.ACCESSION NUMBERS
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